ESPriT1: the effectiveness of laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: a randomised controlled feasibility trial

In: Reproduction and Fertility · 2026 · vol. 7(2) · doi:10.1530/raf-26-0043 · PMID:42160242 · PMC13232596 · W7161755030
article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-08

This feasibility trial found that 31% of women with suspected endometriosis undergoing laparoscopy consented to participate in a randomized trial comparing surgical removal of superficial peritoneal endometriosis versus sham surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

This randomised controlled feasibility trial studied whether laparoscopic treatment for isolated superficial peritoneal endometriosis could reduce chronic pelvic pain in women, using trial methods that assessed feasibility alongside clinical outcomes. The study design involved a lead site and statistical analyses performed by the trial team, with the key finding being reported as part of feasibility testing rather than definitive effectiveness. The paper explicitly frames the work as feasibility, implying limitations in power to confirm efficacy. This paper is centrally about endometriosis — it evaluates laparoscopic treatment specifically for isolated superficial peritoneal endometriosis to manage chronic pelvic pain.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Lay summary: Endometriosis is a chronic pain condition that affects >190 million people worldwide. It is recommended in clinical guidelines to remove the most common type of endometriosis, 'superficial peritoneal endometriosis' (SPE), if it is diagnosed at laparoscopy (keyhole surgery). However, the evidence to support removal of SPE is based on small studies with short-term follow-up. The aim of this small feasibility trial was to determine what proportion of women with pelvic pain undergoing laparoscopy for suspected endometriosis would be willing to be randomly allocated to have surgical removal of SPE or not have it treated surgically straightaway (sham surgery). Of the eligible patients that were approached, 31% consented to take part, demonstrating that people with endometriosis are willing to take part in a sham surgical trial. We are now leading a similar, but much larger UK-wide trial, to determine whether removal of SPE truly improves painful endometriosis symptoms.
Full text 1,398 characters · extracted from pmc-nxml · 3 sections · click to expand

Funding

This research was funded by MRC (Grant No. MR/N022556/1) and the Chief Scientist Office (Award No. TCS/18/43).

Coi Statement

LHRW received grant funding from the NIHR, UKRI, Chief Scientist’s Office and Wellbeing of Women. LHRW’s institution received grant funding from Roche Diagnostics and honoraria for teaching from Gedeon Richter and Theramex. JPD received grant funding from the NIHR, Chief Scientist’s Office and Wellbeing of Women. AWH received grant funding from the NIHR, MRC, Chief Scientist’s Office, Wellcome Trust, Wellbeing of Women, Ferring and Roche. AWH’s institution received honoraria for consultancy from Roche Diagnostics, Gesynta and Joii; grant funding from Roche Diagnostics; and honoraria for teaching from Gedeon Richter. AWH has received lecture fees from Theramex. The other authors declare no competing interests. A W Horne is co-Editor-in-Chief of Reproduction & Fertility and was not involved in the review or editorial process for this paper, on which he is listed as an author.

Author Contributions

All authors contributed to the conception, design and delivery of the study. AWH and JPD secured funding. AWH, LHRW, JPD, JS and LJW were the trial management group. LHRW was PI for the lead site. JS and LJW performed the statistical analyses. LHRW, LJW, JS and AWH drafted the report, and all authors provided input to editing for publication and accept responsibility to submit for publication.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

EHP-30

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK